Soliman, A.; Pippa, L.F.; Lass, J.; Leroux, S.; Vozmediano, V.; de Moraes, N.V.
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants. Pharmaceuticals 2025, 18, 355.
https://doi.org/10.3390/ph18030355
AMA Style
Soliman A, Pippa LF, Lass J, Leroux S, Vozmediano V, de Moraes NV.
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants. Pharmaceuticals. 2025; 18(3):355.
https://doi.org/10.3390/ph18030355
Chicago/Turabian Style
Soliman, Amira, Leandro F. Pippa, Jana Lass, Stephanie Leroux, Valvanera Vozmediano, and Natalia V. de Moraes.
2025. "Model-Informed Dose Optimization of Spironolactone in Neonates and Infants" Pharmaceuticals 18, no. 3: 355.
https://doi.org/10.3390/ph18030355
APA Style
Soliman, A., Pippa, L. F., Lass, J., Leroux, S., Vozmediano, V., & de Moraes, N. V.
(2025). Model-Informed Dose Optimization of Spironolactone in Neonates and Infants. Pharmaceuticals, 18(3), 355.
https://doi.org/10.3390/ph18030355